HEADER HYDROLASE/HYDROLASE INHIBITOR 02-OCT-14 4WKB TITLE CRYSTAL STRUCTURE OF VIBRIO CHOLERAE 5'-METHYLTHIOADENOSINE/S-ADENOSYL TITLE 2 HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH METHYLTHIO-DADME- TITLE 3 IMMUCILLIN-A COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MTAN,5'-METHYLTHIOADENOSINE NUCLEOSIDASE,MTA NUCLEOSIDASE,S- COMPND 5 ADENOSYLHOMOCYSTEINE NUCLEOSIDASE,SRH NUCLEOSIDASE; COMPND 6 EC: 3.2.2.9; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VIBRIO CHOLERAE SEROTYPE O1; SOURCE 3 ORGANISM_TAXID: 345073; SOURCE 4 STRAIN: ATCC 39541 / CLASSICAL OGAWA 395 / O395; SOURCE 5 GENE: MTNN, PFS, VC0395_A1957, VC395_2494; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PDEST14 KEYWDS HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.A.CAMERON,K.THOMAS,S.C.ALMO,V.L.SCHRAMM REVDAT 4 27-SEP-23 4WKB 1 REMARK REVDAT 3 25-DEC-19 4WKB 1 REMARK REVDAT 2 20-SEP-17 4WKB 1 JRNL REMARK REVDAT 1 19-AUG-15 4WKB 0 JRNL AUTH K.THOMAS,S.A.CAMERON,S.C.ALMO,E.S.BURGOS,S.A.GULAB, JRNL AUTH 2 V.L.SCHRAMM JRNL TITL ACTIVE SITE AND REMOTE CONTRIBUTIONS TO CATALYSIS IN JRNL TITL 2 METHYLTHIOADENOSINE NUCLEOSIDASES. JRNL REF BIOCHEMISTRY V. 54 2520 2015 JRNL REFN ISSN 0006-2960 JRNL PMID 25806409 JRNL DOI 10.1021/BI501487W REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.A.GUTIERREZ,T.CROWDER,A.RINALDO-MATTHIS,M.-C.HO,S.C.ALMO, REMARK 1 AUTH 2 V.L.SCHRAMM REMARK 1 TITL TRANSITION STATE ANALOGS OF 5'-METHYLTHIOADENOSINE REMARK 1 TITL 2 NUCLEOSIDASE DISRUPT QUORUM SENSING REMARK 1 REF NAT.CHEM.BIOL. 251 2009 REMARK 1 REFN ISSN 1552-4450 REMARK 1 PMID 19270684 REMARK 1 DOI 10.1038/NCHEMBIO.153 REMARK 2 REMARK 2 RESOLUTION. 1.37 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.37 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 3 NUMBER OF REFLECTIONS : 80872 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.183 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 4126 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.37 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.41 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6327 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.2080 REMARK 3 BIN FREE R VALUE SET COUNT : 317 REMARK 3 BIN FREE R VALUE : 0.2340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3535 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 431 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.23000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : -0.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.69000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.059 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.058 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.034 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.810 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.963 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3686 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3590 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5011 ; 1.367 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8260 ; 0.755 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 488 ; 5.959 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 150 ;36.684 ;25.800 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 619 ;10.675 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;10.599 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 598 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4224 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 804 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1910 ; 0.724 ; 1.234 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1909 ; 0.724 ; 1.234 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2388 ; 1.199 ; 1.851 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4WKB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-OCT-14. REMARK 100 THE DEPOSITION ID IS D_1000203927. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-AUG-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : DOUBLE SILICON(111) CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 85031 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.370 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.770 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3DP9 REMARK 200 REMARK 200 REMARK: BLOCK REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN (10 MG/ML); RESERVOIR (0.1M DI REMARK 280 -AMMONIUM HYDROGEN CITRATE AND 15% PEG 3350); CRYOPROTECTION (20% REMARK 280 (V/V) GLYCEROL), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.00100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 238 REMARK 465 HIS A 239 REMARK 465 HIS A 240 REMARK 465 HIS A 241 REMARK 465 HIS A 242 REMARK 465 HIS A 243 REMARK 465 HIS A 244 REMARK 465 GLY B 238 REMARK 465 HIS B 239 REMARK 465 HIS B 240 REMARK 465 HIS B 241 REMARK 465 HIS B 242 REMARK 465 HIS B 243 REMARK 465 HIS B 244 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 202 CD CE NZ REMARK 470 LYS A 231 CE NZ REMARK 470 GLN B 10 CD OE1 NE2 REMARK 470 GLU B 123 CD OE1 OE2 REMARK 470 GLN B 237 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 150 46.99 -83.85 REMARK 500 CYS A 154 24.65 -149.24 REMARK 500 GLU A 173 -162.83 -161.91 REMARK 500 ASP B 150 47.28 -84.36 REMARK 500 CYS B 154 23.75 -153.16 REMARK 500 GLU B 173 -163.56 -164.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 537 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A 629 DISTANCE = 6.48 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TDI A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TDI B 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DP9 RELATED DB: PDB REMARK 900 3DP9 CONTAINS THE SAME PROTEIN COMPLEXED WITH BUTYLTHIO-DADME- REMARK 900 IMMUCILLIN A DBREF 4WKB A 1 231 UNP A5F5R2 MTNN_VIBC3 1 231 DBREF 4WKB B 1 231 UNP A5F5R2 MTNN_VIBC3 1 231 SEQADV 4WKB GLU A 232 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB ASN A 233 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB LEU A 234 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB TYR A 235 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB PHE A 236 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB GLN A 237 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB GLY A 238 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS A 239 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS A 240 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS A 241 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS A 242 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS A 243 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS A 244 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB GLU B 232 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB ASN B 233 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB LEU B 234 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB TYR B 235 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB PHE B 236 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB GLN B 237 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB GLY B 238 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS B 239 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS B 240 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS B 241 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS B 242 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS B 243 UNP A5F5R2 EXPRESSION TAG SEQADV 4WKB HIS B 244 UNP A5F5R2 EXPRESSION TAG SEQRES 1 A 244 MET LYS ILE GLY ILE ILE GLY ALA MET GLN GLN GLU VAL SEQRES 2 A 244 ALA ILE LEU LYS ASP LEU ILE GLU ASP VAL GLN GLU VAL SEQRES 3 A 244 ASN GLN ALA GLY CYS THR PHE TYR SER GLY GLN ILE GLN SEQRES 4 A 244 GLY VAL ASP VAL VAL LEU LEU GLN SER GLY ILE GLY LYS SEQRES 5 A 244 VAL SER ALA ALA LEU GLY THR ALA LEU LEU ILE SER GLN SEQRES 6 A 244 TYR ALA PRO ASP VAL VAL ILE ASN THR GLY SER ALA GLY SEQRES 7 A 244 GLY PHE ASP ALA SER LEU ASN VAL GLY ASP VAL VAL ILE SEQRES 8 A 244 SER SER GLU VAL ARG HIS HIS ASP ALA ASP VAL THR ALA SEQRES 9 A 244 PHE GLY TYR GLU ILE GLY GLN MET ALA GLY GLN PRO ALA SEQRES 10 A 244 ALA PHE LYS ALA ASP GLU LYS LEU MET THR VAL ALA GLU SEQRES 11 A 244 GLN ALA LEU ALA GLN LEU PRO ASN THR HIS ALA VAL ARG SEQRES 12 A 244 GLY LEU ILE CYS THR GLY ASP ALA PHE VAL CYS THR ALA SEQRES 13 A 244 GLU ARG GLN GLN PHE ILE ARG GLN HIS PHE PRO SER VAL SEQRES 14 A 244 VAL ALA VAL GLU MET GLU ALA SER ALA ILE ALA GLN THR SEQRES 15 A 244 CYS HIS GLN PHE LYS VAL PRO PHE VAL VAL VAL ARG ALA SEQRES 16 A 244 ILE SER ASP VAL ALA ASP LYS GLU SER PRO LEU SER PHE SEQRES 17 A 244 GLU GLU PHE LEU PRO LEU ALA ALA LYS SER SER SER ALA SEQRES 18 A 244 MET VAL LEU LYS MET VAL GLU LEU LEU LYS GLU ASN LEU SEQRES 19 A 244 TYR PHE GLN GLY HIS HIS HIS HIS HIS HIS SEQRES 1 B 244 MET LYS ILE GLY ILE ILE GLY ALA MET GLN GLN GLU VAL SEQRES 2 B 244 ALA ILE LEU LYS ASP LEU ILE GLU ASP VAL GLN GLU VAL SEQRES 3 B 244 ASN GLN ALA GLY CYS THR PHE TYR SER GLY GLN ILE GLN SEQRES 4 B 244 GLY VAL ASP VAL VAL LEU LEU GLN SER GLY ILE GLY LYS SEQRES 5 B 244 VAL SER ALA ALA LEU GLY THR ALA LEU LEU ILE SER GLN SEQRES 6 B 244 TYR ALA PRO ASP VAL VAL ILE ASN THR GLY SER ALA GLY SEQRES 7 B 244 GLY PHE ASP ALA SER LEU ASN VAL GLY ASP VAL VAL ILE SEQRES 8 B 244 SER SER GLU VAL ARG HIS HIS ASP ALA ASP VAL THR ALA SEQRES 9 B 244 PHE GLY TYR GLU ILE GLY GLN MET ALA GLY GLN PRO ALA SEQRES 10 B 244 ALA PHE LYS ALA ASP GLU LYS LEU MET THR VAL ALA GLU SEQRES 11 B 244 GLN ALA LEU ALA GLN LEU PRO ASN THR HIS ALA VAL ARG SEQRES 12 B 244 GLY LEU ILE CYS THR GLY ASP ALA PHE VAL CYS THR ALA SEQRES 13 B 244 GLU ARG GLN GLN PHE ILE ARG GLN HIS PHE PRO SER VAL SEQRES 14 B 244 VAL ALA VAL GLU MET GLU ALA SER ALA ILE ALA GLN THR SEQRES 15 B 244 CYS HIS GLN PHE LYS VAL PRO PHE VAL VAL VAL ARG ALA SEQRES 16 B 244 ILE SER ASP VAL ALA ASP LYS GLU SER PRO LEU SER PHE SEQRES 17 B 244 GLU GLU PHE LEU PRO LEU ALA ALA LYS SER SER SER ALA SEQRES 18 B 244 MET VAL LEU LYS MET VAL GLU LEU LEU LYS GLU ASN LEU SEQRES 19 B 244 TYR PHE GLN GLY HIS HIS HIS HIS HIS HIS HET TDI A 301 20 HET TDI B 301 20 HETNAM TDI (3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL) HETNAM 2 TDI METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL HETSYN TDI (3R,4S)-1-[9-DEAZAADENIN-9-YL)METHYL]-3-HYDROXY-4- HETSYN 2 TDI (METHYLTHIOMETHYL)PYRROLIDINE FORMUL 3 TDI 2(C13 H19 N5 O S) FORMUL 5 HOH *431(H2 O) HELIX 1 AA1 MET A 9 ILE A 20 1 12 HELIX 2 AA2 GLY A 51 ALA A 67 1 17 HELIX 3 AA3 VAL A 102 GLY A 106 5 5 HELIX 4 AA4 ASP A 122 GLN A 135 1 14 HELIX 5 AA5 THR A 155 PHE A 166 1 12 HELIX 6 AA6 GLU A 175 LYS A 187 1 13 HELIX 7 AA7 GLU A 203 LEU A 234 1 32 HELIX 8 AA8 MET B 9 LEU B 19 1 11 HELIX 9 AA9 GLY B 51 ALA B 67 1 17 HELIX 10 AB1 VAL B 102 GLY B 106 5 5 HELIX 11 AB2 ASP B 122 GLN B 135 1 14 HELIX 12 AB3 THR B 155 PHE B 166 1 12 HELIX 13 AB4 GLU B 175 LYS B 187 1 13 HELIX 14 AB5 GLU B 203 GLU B 232 1 30 SHEET 1 AA1 9 GLU A 21 GLN A 28 0 SHEET 2 AA1 9 CYS A 31 ILE A 38 -1 O GLN A 37 N GLU A 21 SHEET 3 AA1 9 VAL A 41 GLN A 47 -1 O LEU A 45 N TYR A 34 SHEET 4 AA1 9 LYS A 2 GLY A 7 1 N ILE A 5 O LEU A 46 SHEET 5 AA1 9 VAL A 70 GLY A 79 1 O VAL A 70 N GLY A 4 SHEET 6 AA1 9 VAL A 169 GLU A 173 -1 O VAL A 172 N GLY A 78 SHEET 7 AA1 9 ALA A 141 THR A 148 1 N LEU A 145 O VAL A 170 SHEET 8 AA1 9 VAL A 89 HIS A 97 1 N ARG A 96 O THR A 148 SHEET 9 AA1 9 PHE A 119 LYS A 120 -1 O PHE A 119 N VAL A 95 SHEET 1 AA2 8 GLU A 21 GLN A 28 0 SHEET 2 AA2 8 CYS A 31 ILE A 38 -1 O GLN A 37 N GLU A 21 SHEET 3 AA2 8 VAL A 41 GLN A 47 -1 O LEU A 45 N TYR A 34 SHEET 4 AA2 8 LYS A 2 GLY A 7 1 N ILE A 5 O LEU A 46 SHEET 5 AA2 8 VAL A 70 GLY A 79 1 O VAL A 70 N GLY A 4 SHEET 6 AA2 8 PHE A 190 ASP A 198 1 O ASP A 198 N GLY A 79 SHEET 7 AA2 8 VAL A 89 HIS A 97 -1 N VAL A 90 O ARG A 194 SHEET 8 AA2 8 PHE A 119 LYS A 120 -1 O PHE A 119 N VAL A 95 SHEET 1 AA3 9 GLU B 21 GLN B 28 0 SHEET 2 AA3 9 CYS B 31 ILE B 38 -1 O GLN B 37 N GLU B 21 SHEET 3 AA3 9 VAL B 41 GLN B 47 -1 O LEU B 45 N TYR B 34 SHEET 4 AA3 9 LYS B 2 GLY B 7 1 N ILE B 5 O LEU B 46 SHEET 5 AA3 9 VAL B 70 GLY B 79 1 O VAL B 70 N GLY B 4 SHEET 6 AA3 9 VAL B 169 GLU B 173 -1 O VAL B 172 N GLY B 78 SHEET 7 AA3 9 ALA B 141 THR B 148 1 N LEU B 145 O VAL B 170 SHEET 8 AA3 9 VAL B 89 HIS B 97 1 N ARG B 96 O THR B 148 SHEET 9 AA3 9 PHE B 119 LYS B 120 -1 O PHE B 119 N VAL B 95 SHEET 1 AA4 8 GLU B 21 GLN B 28 0 SHEET 2 AA4 8 CYS B 31 ILE B 38 -1 O GLN B 37 N GLU B 21 SHEET 3 AA4 8 VAL B 41 GLN B 47 -1 O LEU B 45 N TYR B 34 SHEET 4 AA4 8 LYS B 2 GLY B 7 1 N ILE B 5 O LEU B 46 SHEET 5 AA4 8 VAL B 70 GLY B 79 1 O VAL B 70 N GLY B 4 SHEET 6 AA4 8 PHE B 190 ASP B 198 1 O ASP B 198 N GLY B 79 SHEET 7 AA4 8 VAL B 89 HIS B 97 -1 N VAL B 90 O ARG B 194 SHEET 8 AA4 8 PHE B 119 LYS B 120 -1 O PHE B 119 N VAL B 95 SITE 1 AC1 14 ILE A 50 SER A 76 ALA A 77 GLY A 78 SITE 2 AC1 14 ALA A 151 PHE A 152 VAL A 153 GLU A 173 SITE 3 AC1 14 MET A 174 GLU A 175 SER A 197 ASP A 198 SITE 4 AC1 14 PHE A 208 HOH A 485 SITE 1 AC2 15 PHE A 105 ILE B 50 SER B 76 ALA B 77 SITE 2 AC2 15 GLY B 78 ALA B 151 PHE B 152 VAL B 153 SITE 3 AC2 15 GLU B 173 MET B 174 GLU B 175 SER B 197 SITE 4 AC2 15 ASP B 198 PHE B 208 HOH B 471 CRYST1 53.192 72.002 61.648 90.00 110.32 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018800 0.000000 0.006961 0.00000 SCALE2 0.000000 0.013889 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017297 0.00000